Quantcast
Last updated on April 24, 2014 at 1:21 EDT

Latest Statin Stories

2013-11-13 23:03:32

The Firm is now investigating Lipitor lawsuits on behalf of individuals who developed new-onset Type 2 diabetes, allegedly due to their use of Lipitor. (PRWEB) November 13, 2013 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in courts around the country, as Bernstein Liebhard LLP notes the filing of a new claim in West Virginia Federal Court on behalf of a woman who allegedly developed new-onset Type 2 diabetes due to her use of the cholesterol –lowering drug....

Cholesterol Guidelines Updated
2013-11-13 11:38:29

[ Watch the Video: Statins Should Be Prescribed To More People ] Brett Smith for redOrbit.com - Your Universe Online Cholesterol-lowering drugs should be prescribed to about 33 million more Americans, according to new guidelines for healthcare providers recently released by a joint committee from the American Heart Association and American College of Cardiology. The new guidelines said those without cardiovascular disease, but who have a 7.5 percent or higher risk for a heart attack...

2013-11-12 08:37:02

First Long-Term Data of a PCSK9 Inhibitor to be Featured in Clinical Science: Special Reports Session THOUSAND OAKS, Calif., Nov. 12, 2013 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that it will present new data on evolocumab (AMG 145), an investigational fully human monoclonal antibody that inhibits PCSK9, a protein that reduces the liver's ability to remove low-density lipoprotein cholesterol (LDL-C), or "bad" cholesterol, from the blood(1), at the upcoming American Heart...

2013-11-04 08:26:45

"RVX-208 lowers Inflammation and MACE Events while Regressing Atheroma in High Risk CVD Patients" TSX Exchange Symbol: RVX CALGARY, Nov. 4, 2013 /PRNewswire/ - Resverlogix Corp. (TSX:RVX) today announced two additional results from the ongoing analysis of its Phase 2b ASSURE clinical trial using intravascular ultrasound (IVUS) to study high-risk cardiovascular disease (CVD) patients for assessing benefits of RVX-208. This lead molecule is a member of a new class of compounds...

2013-10-29 23:35:25

Attorney Paul d’Oliveira alerts patients taking Lipitor that recent studies have linked the drug to type 2 diabetes and other complications. The law firm works with some of the more experienced Lipitor lawyers, who charge no fee unless and until the client gets a settlement or award. (PRWEB) October 29, 2013 A series of medical studies have investigated the effects of the drug Lipitor. According to U.S. News, patients who take statin drugs like Lipitor “may slightly increase their...

Study Challenges Risk Of Saturated Fats
2013-10-25 10:50:59

redOrbit Staff & Wire Reports - Your Universe Online The cardiovascular risk of eating butter, cheese, red meat and other foods high in saturated fat has been overstated, and the cholesterol-lowering drugs known as statins are being overprescribed, according to new research appearing in the latest edition of the British Medical Journal. Study author Aseem Malhotra, and interventional cardiology specialist registrar at Croydon University Hospital in London, wrote that while “the...

2013-10-18 23:25:27

Plaintiff in Lipitor Lawsuit Is Seeking to Have All Federal Claims Involving Allegations of Type 2 Diabetes Consolidated in a Multidistrict Litigation in South Carolina Federal Court Columbus, OH (PRWEB) October 18, 2013 Lipitor lawsuits are now being evaluated by Wright & Schulte LLC, an experienced personal injury law firm, on behalf of individuals who allegedly developed Type 2 diabetes due to their use of Lipitor. According to court documents, a Plaintiff in a Lipitor lawsuit...

2013-10-16 00:20:44

Alirocumab monotherapy reduced "bad" cholesterol three times more than ezetimibe PARIS and TARRYTOWN, N.Y., Oct. 16, 2013 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the Phase 3 ODYSSEY MONO trial with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), met its primary efficacy endpoint. The mean low-density lipoprotein-cholesterol (LDL-C,...

2013-10-15 23:02:51

The Firm is investigating Lipitor lawsuits on behalf of patients who developed Type 2 diabetes, allegedly due to their use of Lipitor. New York, New York (PRWEB) October 15, 2013 Lipitor lawsuits (http://www.thelipitorlawsuit.com/) continue to mount in courts around the country, prompting a plaintiff who allegedly developed Type 2 diabetes from their use of the statin to file a second motion seeking the establishment of a multidistrict litigation for all federally-filed Lipitor claims,...

2013-10-14 12:24:40

SAN DIEGO, Oct. 14, 2013 /PRNewswire/ -- According to the Centers for Disease Control and Prevention, cataracts are the number one cause of vision loss in the United States. Nearly 22 million Americans age 40 and over have cataracts, while more than half of individuals age 80 and over suffer from this condition. In a recent study released in JAMA Ophthalmology, it was confirmed that statins, which are typically prescribed to reduce cholesterol and also prevent heart disease, may cause an...